CorVel Corp
General ticker "CRVL" information:
- Sector: Health Care
- Industry: Health Care Providers & Services
- Capitalization: $6.1B
CorVel Corp follows the US Stock Market performance with the rate: 67.3%.
Estimated limits based on current volatility of 2.6%: low 334.31$, high 351.92$
Factors to consider:
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-03-31 to 2026-03-31
- 2024-03-31 to 2025-03-31 estimated range: [219.57$, 317.89$]
- 2025-03-31 to 2026-03-31 estimated range: [241.40$, 346.44$]
Financial Metrics affecting the CRVL estimates:
- Positive: Non-GAAP EPS, $ of 4.40 > 2.29
- Positive: 9.05 < Operating profit margin, % of 11.96
- Positive: -3.48 < Investing cash flow per share, $ of -1.71
- Negative: Industry operating profit margin (median), % of 1.01 <= 2.14
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Return on assets ratio (scaled to [-100,100]) of 13.85 > 7.10
Short-term CRVL quotes
Long-term CRVL plot with estimates
Financial data
YTD | 2022-03-31 | 2023-03-31 | 2024-03-31 |
---|---|---|---|
Operating Revenue | $646.23MM | $718.56MM | $795.31MM |
Operating Expenses | $585.63MM | $659.13MM | $700.21MM |
Operating Income | $60.60MM | $59.43MM | $95.10MM |
Non-Operating Income | $23.92MM | $25.12MM | $0.00MM |
Income(Loss) | $84.51MM | $84.55MM | $95.10MM |
Taxes | $18.10MM | $18.19MM | $18.85MM |
Profit(Loss) | $66.41MM | $66.36MM | $76.25MM |
Stockholders Equity | $212.40MM | $202.18MM | $247.65MM |
Assets | $415.25MM | $393.92MM | $454.68MM |
Operating Cash Flow | $67.22MM | $82.29MM | $99.24MM |
Capital expenditure | $29.82MM | $26.32MM | $29.24MM |
Investing Cash Flow | $-29.82MM | $-26.32MM | $-29.24MM |
Financing Cash Flow | $-79.61MM | $-82.14MM | $-35.76MM |
Earnings Per Share* | $3.74 | $3.83 | $4.45 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.